Masimo Corporation (NASDAQ:MASI) Receives Average Recommendation of “Moderate Buy” from Analysts

Masimo Corporation (NASDAQ:MASI) has been given an average rating of “Moderate Buy” by the eight analysts that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, five have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $194.60.

Several equities analysts recently issued reports on MASI shares. Piper Sandler increased their target price on Masimo from $200.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 6th. BTIG Research reissued a “buy” rating and set a $198.00 target price on shares of Masimo in a research note on Thursday, September 11th. Weiss Ratings restated a “sell (d)” rating on shares of Masimo in a report on Wednesday, October 8th. Zacks Research upgraded Masimo from a “hold” rating to a “strong-buy” rating in a report on Wednesday, September 3rd. Finally, Wall Street Zen upgraded Masimo from a “hold” rating to a “buy” rating in a report on Tuesday, October 14th.

Insiders Place Their Bets

In related news, Director William R. Jellison purchased 3,000 shares of the business’s stock in a transaction on Monday, August 11th. The shares were bought at an average price of $145.98 per share, for a total transaction of $437,940.00. Following the acquisition, the director directly owned 4,790 shares in the company, valued at $699,244.20. This trade represents a 167.60% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 16.90% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the business. Nordea Investment Management AB increased its holdings in shares of Masimo by 2.0% in the 3rd quarter. Nordea Investment Management AB now owns 32,499 shares of the medical equipment provider’s stock valued at $4,687,000 after acquiring an additional 631 shares during the last quarter. Harbor Investment Advisory LLC increased its holdings in shares of Masimo by 66.5% in the 3rd quarter. Harbor Investment Advisory LLC now owns 999 shares of the medical equipment provider’s stock valued at $147,000 after acquiring an additional 399 shares during the last quarter. Cardinal Capital Management increased its holdings in shares of Masimo by 4.7% in the 3rd quarter. Cardinal Capital Management now owns 21,180 shares of the medical equipment provider’s stock valued at $3,125,000 after acquiring an additional 943 shares during the last quarter. KLP Kapitalforvaltning AS increased its holdings in shares of Masimo by 4.3% in the 3rd quarter. KLP Kapitalforvaltning AS now owns 9,800 shares of the medical equipment provider’s stock valued at $1,446,000 after acquiring an additional 400 shares during the last quarter. Finally, Louisiana State Employees Retirement System increased its holdings in shares of Masimo by 1.6% in the 3rd quarter. Louisiana State Employees Retirement System now owns 12,900 shares of the medical equipment provider’s stock valued at $1,903,000 after acquiring an additional 200 shares during the last quarter. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Masimo Price Performance

MASI opened at $148.00 on Tuesday. The stock’s 50-day moving average price is $145.08 and its 200 day moving average price is $154.38. Masimo has a 12-month low of $133.70 and a 12-month high of $194.88. The company has a current ratio of 2.14, a quick ratio of 1.61 and a debt-to-equity ratio of 0.57. The firm has a market cap of $8.04 billion, a price-to-earnings ratio of -17.37 and a beta of 1.28.

Masimo (NASDAQ:MASI) last posted its earnings results on Thursday, June 20th. The medical equipment provider reported $1.42 earnings per share (EPS) for the quarter. Masimo had a positive return on equity of 26.54% and a negative net margin of 24.85%.The firm had revenue of $617.00 million for the quarter. As a group, sell-side analysts expect that Masimo will post 4.1 earnings per share for the current year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.